AzTrials
AzTrials

Cochlear DiseasesTELESURVICNCT03874533

Remote Monitoring Applied to Cochlear Implant Patient Follow-up

A study testing Self-adjustment tests in people with Cochlear Diseases, run by Assistance Publique - Hôpitaux de Paris.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The cochlear implant (CI) is a device to compensate severe or profound deafness. The CI has a lifetime implanted part and an external processor. Regular monitoring is necessary because the device can generate complications and when the device is dysfunctional, the patient becomes deaf again. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cochlear Diseases
What is being tested?
Self-adjustment tests
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
Mar 2019to Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years old
  • Cochlear implantation older than 6 months (with a COCHLEAR implant and processor allowing wireless connection), followed by CRIC or IFIC,
  • Fluent in the French language,
  • Possibility of carrying out the acts alone in person in the service within a short time (less than 30 days).
  • Patients affiliated to a social security scheme or entitled to it
  • Patient who has signed informed consent form

Who cannot join

  • Difficulty mastering the tests alone or handling the tablet that will be entrusted to him
  • Persons deprived of their liberty by judicial or administrative decision
  • Persons hospitalized without consent and without legal protection, and persons admitted to a health or social institution for purposes other than research.
  • Adults who are subject to a legal protection measure (guardianship, trusteeship or judicial protection), adults who are unable to express their consent and are not subject to a protection measure

Trial locations and contacts

No sites are listed yet.

Christine PONCET WALLET, MD contact

+33 1 40 19 36 61

christine.poncet@aphp.fr

About this study

Official title: Remote Monitoring Applied to Cochlear Implant Patient Follow-up (TELESURVIC)

The cochlear implant (CI) is a device to compensate severe or profound deafness. The CI has a lifetime implanted part and an external processor. Regular monitoring is necessary because the device can generate complications and when the device is dysfunctional, the patient becomes deaf again. Our center, the CRIC, is a center for monitoring and fitting CI. Follow-up requires face-to-face procedures and some patients have difficulty accessing the center.

Our cohort of patients is growing steadily and now exceeds 750 patients. Provision should be made for sustained steady growth and enabling means. Telemedicine may be a response for the follow-up of some patients.

Read more

Currently, cochlear implanted patients benefit once a year from: an ENT (Ear Nose and Throat) medical consultation, a speech-language assessment, physical verification of the external processor, an audiometric test, a fitting of the external processor. This makes it possible to check the absence of medical complication, the use and the correct functioning of the external and internal parts.

Provision should be made for sustained steady growth and enabling means. With the development of new hearing tests, technical possibilities of some speech processors and software for their fitting, telemedicine may be a response for the follow-up of some patients.

TELESURVIC will study the feasibility for patients implanted with an implant Cochlear™ to carry out a complete test of their equipment by themselves.

For this project we will use a tablet device, without simultaneous contact with CRIC professionals. On this tablet are installed calibrated hearing tests, tutorials of good maintenance of the processor and a software of adjustment allowing the realization of the operations desired for an inspection of the implant.

Patients selected to participate, (on a voluntary basis), in this protocol will follow the following steps:

  1. They will first be trained in the use of the tablet at the CRIC by professionals. Patients will only be included if they are autonomous in handling the tablet and specific software;
  2. They will carry out the various tests at the hospital on the tablet: audiometry test in quiet and in noise then checking of the data logging, self-fitting thanks to the Cochlear software (NFS);
  3. Between one week and one month later, they will come back to the center and will do the same tests alone in a quiet room of the center.
  4. Outside the patient's presence, the data will be analyzed and compared with the data collected in step 2, in order to validate or not, the feasibility of these self-administrated tests without any help by the team.
Read the detailed description

The selection of the patients is made on study of the files of the cochlear implanted patients with leading implant COCHLEARTM, compatible external processor with the research and being able to potentially realize only the studied acts.

The unit proposes then during a consultation or by explanatory e-mail, to the patient to participate in a training workshop. The information note will be presented to the patient during the consultation, or sent by e-mail.

After checking the selection criteria and signing the consent by the patient, the patient joins a training workshop.

During the workshop, bringing together 3 to 5 patients supervised by an ENT doctor of the +/- adjuster team, a speech therapist and +/- a COCHLEARTM engineer, patients will be trained in the handling of the tablet and software. Then, in a second step, each patient will have to carry out the hearing and self-adjustment tests by themselves in a quiet room in the unit. He will be able to reach a unit professional who can help him.

The patient will benefit from auditory evaluation by a consonants discrimination test and a 3-digit noise test and then an evaluation of the implant and processor parameters using COCHLEARTM NFS tuning software.

It is at the end of this workshop that the unit professionals will judge whether the patient is pursuing the research or not. If the patient continues the research, he will have an appointment to return to the service 8 to 30 days later.

Patients pursuing the research will be invited to complete the end-of-workshop questionnaire.

The patient will return to the follow-up center and will repeat exactly the same acts, alone in a room, 8 to 30 days after the first tests. He will also have the opportunity to be assisted by someone of his choice.

At the end of this visit, the patient will be invited to complete the end-of-research questionnaire.

This follow-up visit will mark the end of the patient's participation in this research, unless there is a need to adjust the device.

Once the tests are completed, health professionals will analyze the data retrieved from the tablet and if needed, will see the patient in adjustment within 8 days maximum if there is a difference between the tests performed at the unit during the inclusion visit and those performed by the patient alone in a distant evaluation.

Self-test data from the patient at the follow-up visit should be identical to the training workshop. If this is not the case, it is therefore essential to know if the difference is due to a poor control of the tests or rather to an anomaly appeared secondarily.

Patients will be reviewed as part of the care in case of need for new settings.

The professionals involved in the research (training workshop and self-test verification) will be invited to complete an evaluation questionnaire

Our approach aims to make the patient aware of how the cochlear implant works, to empower him and to make him responsible for his equipment.

By providing him with training not only in passing evaluation self-tests but also in certain parameters of the setting, we want him to understand the interest of an annual follow-up.

And we want to show that a well-trained patient can participate actively in the follow-up of his cochlear implant thanks to adapted tools and telemedicine.

Total number of subjects selected to participate in the workshop: 40. Inclusion period: 6 months, for 30 selected patients at the end of the workshop.

Duration of participation of each patient: 38 days maximum Total search time: 7 months and 8 days

Being tested
Self-adjustment tests
Keywords
Cochlear Implantation, telemonitoring, training workshop
Medical subject headings
Cochlear Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-adjustment testsDevice

    For patients with an implant Cochlear™, we will be trained during workshop, to use a tablet how to do some tests ; They will do alone, by themselves the tests, just after the workshop and 8 to 30 days later.

    Self audiometric test : digit triplet test, consonants discrimination test, Self-fitting of cochlear implant

Study groups in NCT03874533
Study groupRoleWhat they receive
self-adjustment testsExperimentalFor patients with an implant Cochlear™, we will be trained during workshop, to use a tablet how to do some tests; They will do alone, by themselves the tests, just after the workshop and 8 to 30 days later. Self audiometric test : digit triplet test, consonants discrimination test, Self-fitting of cochlear implant
Receives: Device: Self-adjustment tests

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The degree of auditory rehabilitation achieved with the cochlear implant.

    Comparison of the data collected (The hearing tests 3 digits test and VCV) during the usual evaluations in the department, then in auditory self-test and of the parameters of reaction just after an apprenticeship and at a distance, between 8 to 30 days, of this learning

    Measured: Between day +8 to +30 after the training session

  2. The degree of auditory rehabilitation achieved with the cochlear implant.

    Comparison of the data collected (the electrophysiological measures) during the usual evaluations in the department, then in auditory self-test and of the parameters of reaction just after an apprenticeship and at a distance, between 8 to 30 days, of this learning

    Measured: Between day +8 to +30 after the training session

Secondary outcomes (5)
  1. Estimate the degree of patients satisfaction, on the use of new tools that will be used for remote monitoring

    For the patients: The results of Qualitative Self questionnaire, EVA scale, and free comments, according to the scoring manual, will be aggregated to estimate the degree of satisfaction.

    Measured: Between day +8 to +30 after the training session

  2. Estimate the degree of satisfaction professionals, on the use of new tools that will be used for remote monitoring

    For the professionals: The results of Qualitative Self questionnaire, EVA scale, and free comments, according to the scoring manual, will be aggregated to estimate the degree of satisfaction.

    Measured: Between day +8 to +30 after the training session

  3. Estimate the necessary adaptations of the medical team and patients

    When the patients come back (between Day +8 to Day+30), they do the same tests alone, by themselves. The staff checks if the results are the same as those of the tests at day 0, (without any medical or technical intercurrent event).

    We note the time spent for each test by the patient. Each professional involved in the process of teaching, coaching and assessing the patient through the study will fill a chart detailing his/her actions and keep a record of his/her dedicated time.

    By this approach, we hope building a team adapted to the remote monitoring applied to cochlear implant patient follow-up.

    Measured: Between day +8 to +30 after the training session

  4. Estimate time savings for professionals

    Comparison of the time spent for acts realized in a traditional way and the way according to the protocol, for professionals.

    Measured: Between day +8 to +30 after the training session

  5. Estimate time savings for patients

    Comparison of the time spent for acts realized in a traditional way and the way according to the protocol, for patients.

    Measured: Between day +8 to +30 after the training session

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Mar 2019
  2. Study startMar 2019 (estimated)
  3. Primary completionMar 2019 (estimated)
  4. Study completionSep 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03874533
Sponsor's protocol ID
APHP180004
Acronym
TELESURVIC
Status last verified
Mar 2019
First submitted
30 Aug 2018
Last updated
14 Mar 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Self-adjustment tests in people with Cochlear Diseases, run by Assistance Publique - Hôpitaux de Paris.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Christine PONCET WALLET, MD (+33 1 40 19 36 61, christine.poncet@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The degree of auditory rehabilitation achieved with the cochlear implant. (time frame: Between day +8 to +30 after the training session). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in